WebRivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health. It focuses on promoting a new therapeutic approach that uses the body's natural metabolic processes to improve cellular metabolism and reverse the course of … WebSep 23, 2024 · Executives On The Move: Changes At AN2 Therapeutics, Cabaletta Bio And More 13 Jan 2024. Scrip. Biogen Halves Aduhelm Price, Readies $500m In Cost Cuts 20 Dec 2024. Scrip. Finance Watch: Four New ... Rivus Raises $132m In Series B Cash To Fund Obesity Drug Trials Add a personalized message to your email. Cancel. Send. Please …
Rivus Pharmaceuticals, Inc. - CvilleBioHub
WebSep 22, 2024 · About Rivus Pharmaceuticals Rivus Pharmaceuticals, Inc., a leader in mitochondrial biology, is dedicated to improving cardio-metabolic health by advancing a … WebRivus Pharmaceuticals Overview. Founded Year 2024. Location Charlottesville, United States. Company Stage Series A. Total Funding $35M. Last Funding Round $35M, Series A, Jun 20, 2024. Similar Cos. Sarepta, Tenaya Therapeutics, Esperion Therapeutics, Portola Pharma, Aegerion & 298 others Disclaimer: Total Funding = Total Disclosed Equity … ethan allen ming small media cabinet
Clinical Trial & Pipeline - Phathom Pharmaceuticals
WebPharmaceutical Research and Manufacturers of America WebBrian Liu, MD, is a Principal at Longitude Capital. Dr. Liu is a board observer at Quanta Therapeutics and Rivus Pharmaceuticals. He previously served as a board observer at Endeavor Biomedicines, Inflazome (acquired by Roche), Talaris Therapeutics (TALS), and Vera Therapeutics (VERA). WebRivus is advancing a new therapeutic approach that harnesses the body’s natural metabolic processes to improve cellular metabolism and reverse the course of disease. Metabolic … firefly kingsbury school